Alzheimer's Drug Reverses Cognitive Decline Over 12 Month Period In Early Human Testing

A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer's disease in a new study. Dimebon is the first drug tested for Alzheimer's disease that demonstrated continued improvement in patients over a 12 month period.

Read the whole article on Science Daily

More from Science Daily